Bevacizumab First Matches Aflibercept for Diabetic Macular Edema Bevacizumab First Matches Aflibercept for Diabetic Macular Edema

Results from a randomized trial showed that step therapy for diabetic macular edema with lower-priced bevacizumab followed by pricier aflibercept, when needed, works as well as aflibercept monotherapy.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news